Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Valproic acid is an effective seizure medication with some temporary side effects.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

A girl had rickets due to a gene mutation affecting vitamin D response.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Venlafaxine can cause urinary incontinence in rare cases.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.